The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
The many faces of the adamantyl group in drug design
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
The promise of retinoids to fight against cancer
Altucci, L., & Gronemeyer, H. (2001) · Nature Reviews Cancer · doi:10.1038/35106036 · Cited by 773
Antiviral agents active against influenza A viruses
De Clercq, E. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2175 · Cited by 668
Structural basis for the function and inhibition of an influenza virus proton channel
Stouffer, A. L., Acharya, R., Salom, D., Levine, A. S., Di Costanzo, L., Soto, C. S., Tereshko, V., Nanda, V., Stayrook, S., & DeGrado, W. F. (2008) · Nature · doi:10.1038/nature06528 · Cited by 636
Purinergic signalling and disorders of the central nervous system
Burnstock, G. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2605 · Cited by 634
HIF-1 as a target for drug development
Giaccia, A., Siim, B. G., & Johnson, R. S. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1199 · Cited by 631
Augeri, D. J., Robl, J. A., Betebenner, D. A., Magnin, D. R., Khanna, A., Robertson, J. G., Wang, A., Simpkins, L. M., Taunk, P., Huang, Q., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050261p · Cited by 624
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
Villhauer, E. B., Brinkman, J. A., Naderi, G. B., Burkey, B. F., Dunning, B. E., Prasad, K., Mangold, B. L., Russell, M. E., & Hughes, T. E. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030091l · Cited by 613
Waterhouse, R. (2003) · Molecular Imaging & Biology · doi:10.1016/j.mibio.2003.09.014 · Cited by 567
RAR and RXR modulation in cancer and metabolic disease
Altucci, L., Leibowitz, M. D., Ogilvie, K. M., de Lera, A. R., & Gronemeyer, H. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2397 · Cited by 517
Sawkar, A. R., Cheng, W.-C., Beutler, E., Wong, C.-H., Balch, W. E., & Kelly, J. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192582899 · Cited by 503
Gully, D., Canton, M., Boigegrain, R., Jeanjean, F., Molimard, J. C., Poncelet, M., Gueudet, C., Héaulme, M., Leyris, R., & Brouard, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.65 · Cited by 417
Moosmann, B., & Behl, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.8867 · Cited by 411
Macfarlane, D. P., Forbes, S., & Walker, B. R. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0054 · Cited by 385
Protopopova, M., Hanrahan, C., Nikonenko, B., Samala, R., Chen, P., Gearhart, J., Einck, L., & Nacy, C. A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki319 · Cited by 371
Pharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin Sensitivity
Aerts, J. M., Ottenhoff, R., Powlson, A. S., Grefhorst, A., van Eijk, M., Dubbelhuis, P. F., Aten, J., Kuipers, F., Serlie, M. J., Wennekes, T., et al. (2007) · Diabetes · doi:10.2337/db06-1619 · Cited by 301
Use of the Adamantane Structure in Medicinal Chemistry
Lamoureux, G., & Artavia, G. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710792065027 · Cited by 250
Pharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drug
Jia, L., Tomaszewski, J. E., Hanrahan, C., Coward, L., Noker, P., Gorman, G., Nikonenko, B., & Protopopova, M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705984 · Cited by 231
Tyrphostins and Other Tyrosine Kinase Inhibitors
Levitzki, A., & Mishani, E. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142657 · Cited by 226
Cytochrome p450 enzymes in the generation of commercial products
Guengerich, F. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd792 · Cited by 225
Gully, D., Labeeuw, B., Boigegrain, R., Oury-Donat, F., Bachy, A., Poncelet, M., Steinberg, R., Suaud-Chagny, M. F., Santucci, V., Vita, N., et al. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36482-1 · Cited by 218
Raag, R., & Poulos, T. L. (1991) · Biochemistry · doi:10.1021/bi00224a016 · Cited by 210
Crystal structure of the cytochrome P-450CAM active site mutant Thr252Ala
Raag, R., Martinis, S. A., Sligar, S. G., & Poulos, T. L. (1991) · Biochemistry · doi:10.1021/bi00112a008 · Cited by 208
Lee, R. E., Protopopova, M., Crooks, E., Slayden, R. A., Terrot, M., & Barry, C. E. (2003) · Journal of Combinatorial Chemistry · doi:10.1021/cc020071p · Cited by 207
Deoxynojirimycin: synthesis and biological activity
Hughes, A. B., & Rudge, A. J. (1994) · Natural Product Reports · doi:10.1039/np9941100135 · Cited by 197
Geldenhuys, W. J., Malan, S. F., Bloomquist, J. R., Marchand, A. P., & Van der Schyf, C. J. (2005) · Medicinal Research Reviews · doi:10.1002/med.20013 · Cited by 195
Havale, S. H., & Pal, M. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.01.061 · Cited by 190
Generation of Specific Deoxynojirimycin-type Inhibitors of the Non-lysosomal Glucosylceramidase
Overkleeft, H. S., Renkema, G. H., Neele, J., Vianello, P., Hung, I. O., Strijland, A., van der Burg, A. M., Koomen, G.-J., Pandit, U. K., & Aerts, J. M. F. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26522 · Cited by 186
Gaucher Disease-Associated Glucocerebrosidases Show Mutation-Dependent Chemical Chaperoning Profiles
Sawkar, A. R., Adamski-Werner, S. L., Cheng, W.-C., Wong, C.-H., Beutler, E., Zimmer, K.-P., & Kelly, J. W. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.09.007 · Cited by 183
Kebabian, J. W., Britton, D. R., DeNinno, M. P., Perner, R. J., Smith, L. A., Jenner, P. G., Schoenleber, R. W., & Williams, M. J. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90556-j · Cited by 157
Structure and Function of the Influenza A M2 Proton Channel
Cady, S. D., Luo, W., Hu, F., & Hong, M. (2009) · Biochemistry · doi:10.1021/bi9008837 · Cited by 154
Masereel, B., Rolin, S., Abbate, F., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0109199 · Cited by 151
Lee, K., Kang, J. E., Park, S.-K., Jin, Y., Chung, K.-S., Kim, H.-M., Lee, K., Kang, M. R., Lee, M. K., Song, K. B., et al. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.018 · Cited by 149
(Aryloxyacetylamino)benzoic Acid Analogues: A New Class of Hypoxia-Inducible Factor-1 Inhibitors
Lee, K., Lee, J. H., Boovanahalli, S. K., Jin, Y., Lee, M., Jin, X., Kim, J. H., Hong, Y., & Lee, J. J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0610292 · Cited by 148
Antagonists of the P2X7Receptor. From Lead Identification to Drug Development
Guile, S. D., Alcaraz, L., Birkinshaw, T. N., Bowers, K. C., Ebden, M. R., Furber, M., & Stocks, M. J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801528x · Cited by 146
Yu, Z., Sawkar, A. R., Whalen, L. J., Wong, C., & Kelly, J. W. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060677i · Cited by 144
White, R. E., McCarthy, M.-B., Egeberg, K. D., & Sligar, S. G. (1984) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(84)90015-8 · Cited by 142
The Adamantyl Group in Medicinal Agents. I. Hypoglycemic N-Arylsulfonyl-N'-adamantylureas
Gerzon, K., Krumkalns, E. V., Brindle, R. L., Marshall, F. J., & Root, M. A. (1963) · Journal of Medicinal Chemistry · doi:10.1021/jm00342a029 · Cited by 142
Wennekes, T., van den Berg, R. J. B. H. N., Donker‐Koopman, W. E., van der Marel, G. A., Strijland, A., Aerts, J. M. F. G., & Overkleeft, H. S. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo061280p · Cited by 135
Involvement of DPP‐IV catalytic residues in enzyme–saxagliptin complex formation
Metzler, W. J., Yanchunas, J., Weigelt, C. A., Kish, K., Klei, H. E., Xie, D., Zhang, Y., Corbett, M. J., Tamura, J. K., He, B., et al. (2008) · Protein Science · doi:10.1110/ps.073253208 · Cited by 132
Dhungana, S., White, P. S., & Crumbliss, A. L. (2001) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750100259 · Cited by 129
Kozikowski, A. P., Chen, Y., Gaysin, A. M., Chen, B., D’Annibale, M. A., Suto, C. M., & Langley, B. C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070178x · Cited by 124
Hit-to-Lead studies: The discovery of potent adamantane amide P2X7 receptor antagonists
Baxter, A., Bent, J., Bowers, K. C., Braddock, M., Brough, S., Fagura, M., Lawson, M., McInally, T., Mortimore, M., Robertson, M. J., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.034 · Cited by 124
Ulu, A., Davis, B. B., Tsai, H.-J., Kim, I.-H., Morisseau, C. H. P., İnceoğlu, B., Fiehn, O., Hammock, B. D., & Weiss, R. H. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318185fa3c · Cited by 124
Charpentier, B., Bernardon, J., Eustache, J., Millois, C., Martin, B., Michel, S., & Shroot, B. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00026a006 · Cited by 122
Dong, Y., Chollet, J., Matile, H., Charman, S. A., Chiu, F. C. K., Charman, W. N., Scorneaux, B., Urwyler, H., Tomas, J. S., Scheurer, C., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049040u · Cited by 117
Zn(II)-dependent histone deacetylase inhibitors: Suberoylanilide hydroxamic acid and trichostatin A
Codd, R., Braich, N., Liu, J., Soe, C. Z., & Pakchung, A. A. H. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.05.026 · Cited by 117
Self-citationvan Eijk, M., Aten, J., Bijl, N., Ottenhoff, R., van Roomen, C. P. A. A., Dubbelhuis, P. F., Seemann, I., der Vlugt, K. G., Overkleeft, H. S., ARBEENY, C. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004723 · Cited by 115
Mow, B. M. F., Chandra, J., Svingen, P. A., Hallgren, C. G., Weisberg, E., Kottke, T. J., Narayanan, V. L., Litzow, M. R., Griffin, J. D., Sausville, E. A., et al. (2002) · Blood · doi:10.1182/blood.v99.2.664 · Cited by 115
Ai, L., Lee, M., & Klayman, D. L. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00126a017 · Cited by 112
The Structure−Activity Relationship of the Antimalarial Ozonide Arterolane (OZ277)
Dong, Y., Wittlin, S., Sriraghavan, K., Chollet, J., Charman, S. A., Charman, W. N., Scheurer, C., Urwyler, H., Tomas, J. S., Snyder, C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901473s · Cited by 110
Hayden, F. G., Minocha, A., Spyker, D. A., & Hoffman, H. E. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.2.216 · Cited by 107
Liu, J., Tsai, H.-J., Hwang, S. H., Jones, P. D., Morisseau, C. H. P., & Hammock, B. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00009.x · Cited by 104
Self-citationBodor, N. S., & Buchwald, P. (2005) · The AAPS Journal · doi:10.1208/aapsj070479 · Cited by 102
Purinergic modulation of microglial cell activation
Sperlágh, B., & Illés, P. (2006) · Purinergic Signalling Purinergic Signalling · doi:10.1007/s11302-006-9043-x · Cited by 101
Wennekes, T., Meijer, A. J., Groen, A. K., Boot, R. G., Groener, J. E. M., van Eijk, M., Ottenhoff, R., Bijl, N., der Vlugt, K. G., Song, H., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901281m · Cited by 98
Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1
Olson, S. H., Aster, S. D., Brown, K., Carbin, L., Graham, D. W., Hermanowski‐Vosatka, A., LeGrand, C. B., Mundt, S. S., Robbins, M. A., Schaeffer, J. M., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.06.040 · Cited by 97
Berthiaume, M., Laplante, M., Festuccia, W. T., Gélinas, Y., Poulin, S., Lalonde, J., Joanisse, D. R., Thieringer, R., & Deshaies, Y. (2007) · Endocrinology · doi:10.1210/en.2006-1199 · Cited by 94
Rohde, J. J., Pliushchev, M. A., Sorensen, B. K., Wódka, D., Shuai, Q., Wang, J., Fung, S., Monzon, K., Chiou, W. J. H., Pan, L., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0609364 · Cited by 85
Small Molecule Transcription Factor Mimic
Kwon, Y., Arndt, H., Mao, Q., Choi, Y., Kawazoe, Y., Dervan, P. B., & Uesugi, M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0445140 · Cited by 85
Perez, E., Liu, R., Yang, S., Cai, Z. Y., Covey, D. F., & Simpkins, J. W. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.026 · Cited by 85
Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention.
Aerts, J., Hollak, C., Boot, R., & Groener, A. (2003) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.2003.1273 · Cited by 84
Broom, D. C., Matson, D. J., Bradshaw, E., Buck, M. E., Meade, R., Coombs, S. E., Matchett, M., Ford, K. K., Yu, W., Yuan, J., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141853 · Cited by 80
Salvadori, S., Guerrini, R., Balboni, G., Bianchi, C., Bryant, S. D., Cooper, P. S., & Lazarus, L. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990165m · Cited by 76
Svingen, P. A., Tefferi, A., Kottke, T. J., Kaur, G., Narayanan, V. L., Sausville, E. A., & Kaufmann, S. H. (2000) · PubMed · Cited by 75
Tsuzuki, N., Hama, T., Kawada, M., 蓮井昭博, Konishi, R., Shiwa, S., Ochi, Y., Futaki, S., & Kitagawa, K. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830407 · Cited by 73
Avvaru, B. S., Wagner, J. M., Maresca, A., Scozzafava, A., Robbins, A. H., Supuran, C. T., & McKENNA, R. V. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.06.082 · Cited by 73
Nakabayashi, M., Yamada, S., Yoshimoto, N., Tanaka, T., Igarashi, M., Ikura, T., Ito, N., Makishima, M., Tokiwa, H., DeLuca, H. F., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8004477 · Cited by 73
Le, S. B., Hailer, M. K., Buhrow, S. A., Wang, Q., Flatten, K. S., Pediaditakis, P., Bible, K. C., Lewis, L. D., Sausville, E. A., Pang, Y., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611777200 · Cited by 72
Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells
Chandra, J., Hackbarth, J. S., Le, S. B., Loegering, D. A., Bone, N. D., Bruzek, L. M., Narayanan, V. L., Adjei, A. A., Kay, N. E., Tefferi, A., et al. (2003) · Blood · doi:10.1182/blood-2003-02-0562 · Cited by 70
Adamantane sulfone and sulfonamide 11-β-HSD1 Inhibitors
Sorensen, B. K., Winn, M., Rohde, J., Shuai, Q., Wang, J., Fung, S., Monzon, K., Chiou, W. J. H., Stolarik, D. F., Imade, H. M., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.10.008 · Cited by 66
Mahfoud, R., Mylvaganam, M., Lingwood, C. A., & Fantini, J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200165-jlr200 · Cited by 65
Dong, Y., Tang, Y., Chollet, J., Matile, H., Wittlin, S., Charman, S. A., Charman, W. N., Tomas, J. S., Scheurer, C., Snyder, C., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.05.041 · Cited by 64
DeNinno, M. P., Schoenleber, R. W., Perner, R. J., Lijewski, L., Asin, K. E., Britton, D. R., MacKenzie, R. G., & Kebabian, J. W. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00112a034 · Cited by 63
Furber, M., Alcaraz, L., Bent, J., Beyerbach, A., Bowers, K. C., Braddock, M., Caffrey, M. V., Cladingboel, D. E., Collington, J., Donald, D. K., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm700949w · Cited by 62
A Novel Atypical Retinoid Endowed with Proapoptotic and Antitumor Activity
Cincinelli, R., Dallavalle, S., Merlini, L., Penco, S., Pisano, C., Carminati, P., Giannini, G., Vesci, L., Gaetano, C., Illy, B., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm025593y · Cited by 62
Fotsch, C. H., & Wang, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800369f · Cited by 59
Dawson, M. I., Xia, Z., Liu, G., Fontana, J. A., Farhana, L., Patel, B. B., Arumugarajah, S., Bhuiyan, M., Zhang, X.-K., Han, Y.-H., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0613323 · Cited by 57
Vitamin D Receptor: Ligand Recognition and Allosteric Network
Yamamoto, K., Abe, D., Yoshimoto, N., Choi, M., Yamagishi, K., Tokiwa, H., Shimizu, M., Makishima, M., & Yamada, S. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050795q · Cited by 55
A Wrench-Shaped Synthetic Molecule that Modulates a Transcription Factor−Coactivator Interaction
Shimogawa, H., Kwon, Y., Mao, Q., Kawazoe, Y., Choi, Y., Asada, S., Kigoshi, H., & Uesugi, M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja038855+ · Cited by 55
Mylvaganam, M., & Lingwood, C. A. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0474 · Cited by 54
Inaba, Y., Yamamoto, K., Yoshimoto, N., Matsunawa, M., Uno, S., Yamada, S., & Makishima, M. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032318 · Cited by 52
Liu, J., Obando, D., Schipanski, L. G., Groebler, L. K., Witting, P. K., Kalinowski, D. S., Richardson, D. R., & Codd, R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9016703 · Cited by 51
Self-citationRahman, M. N., Vlahakis, J. Z., Szarek, W. A., Nakatsu, K., & Jia, Z. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800505m · Cited by 50
Sun, S., Yue, P., Chandraratna, R. A. S., Tesfaigzi, Y., Hong, W. K., & Lotan, R. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.3.508 · Cited by 49
Novel Inhibitor of Plasmodium Histone Deacetylase That Cures P. berghei- Infected Mice
Agbor-Enoh, S. T., Seudieu, C., Davidson, E. A., Dritschilo, A., & Jung, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00729-08 · Cited by 49
3‘Sulfogalactolipid Binding Specifically Inhibits Hsp70 ATPase Activity in Vitro
Whetstone, H., & Lingwood, C. A. (2003) · Biochemistry · doi:10.1021/bi026735t · Cited by 49
Novel KCNQ2/Q3 Agonists as Potential Therapeutics for Epilepsy and Neuropathic Pain
Fritch, P. C., McNaughton-Smith, G. A., Amato, G. S., Burns, J. F., Eargle, C. W., Roeloffs, R., Harrison, W., Jones, L. S., & Wickenden, A. D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901497b · Cited by 49
Synthesis and Solution Properties of Deferoxamine Amides
Ihnat, P. M., Vennerstrom, J. L., & Robinson, D. H. (2000) · Journal of Pharmaceutical Sciences · Cited by 49
Conformational States of Cytochrome P450cam Revealed by Trapping of Synthetic Molecular Wires
Hays, A. A., Dunn, A. R., Chiu, R., Gray, H. B., Stout, C. D., & Goodin, D. B. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.09.046 · Cited by 48
Perez, E., Cai, Z. Y., Covey, D. F., & Simpkins, J. W. (2005) · Drug Development Research · doi:10.1002/ddr.20047 · Cited by 46
Anticonvulsant activity of analogues of acetazolamide
Chufán, E. E., Pedregosa, J. C., Baldini, O., & Bruno‐Blanch, L. E. (1999) · Il Farmaco · doi:10.1016/s0014-827x(99)00096-8 · Cited by 45
Xia, S., Cai, Z. Y., Thio, L. L., Kim‐Han, J. S., Dugan, L. L., Covey, D. F., & Rothman, S. M. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0478 · Cited by 44
Zoidis, G., Papanastasiou, I. P., Dotsikas, Y., Sandoval, A., dos Santos, R. G., Papadopoulou‐Daifoti, Z., Vamvakidès, A., Kolocouris, N., & Felix, R. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.02.030 · Cited by 44
Medicinal Chemistry of Incretin Mimetics and DPP‐4 Inhibitors
Zettl, H., Schubert‐Zsilavecz, M., & Steinhilber, D. (2009) · ChemMedChem · doi:10.1002/cmdc.200900448 · Cited by 43
Inhibition of Multidrug Resistance by AdamantylGb3, a Globotriaosylceramide Analog
Rosa, M. F. D., Ackerley, C. A., Wang, B., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705473200 · Cited by 43
Dixon, D. D., Sethumadhavan, D., Benneche, T., Banaag, A. R., Tius, M. A., Thakur, G. A., Bowman, A. L., Wood, J. T., & Makriyannis, A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100390h · Cited by 43
Dawson, M. I., Harris, D. L., Liu, G., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030524k · Cited by 42
Singh, C., Chaudhary, S., & Puri, S. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060826x · Cited by 41
Transcriptional Switches: Chemical Approaches to Gene Regulation
Lee, L. W., & Mapp, A. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r109.075044 · Cited by 41
“The next big thing” in diabetes: clinical progress on DPP‐IV inhibitors
von Geldern, T. W., & Trevillyan, J. M. (2006) · Drug Development Research · doi:10.1002/ddr.20138 · Cited by 40
Structure−Activity Relationship Studies onN′-Aryl Carbohydrazide P2X7Antagonists
Nelson, D. W., Sarris, K., Kalvin, D. M., Namovic, M. T., Grayson, G. K., Donnelly‐Roberts, D. L., Harris, R., Honoré, P., Jarvis, M. F., Faltynek, C. R., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701516f · Cited by 40
A Gene-Expression Inhibitor that Targets an α-Helix-Mediated Protein Interaction
Asada, S., Choi, Y., & Uesugi, M. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0292703 · Cited by 40
Synthesis and pharmacological evaluation of several ring-contracted amantadine analogs
Camps, P., Duque, M. D., Vázquez, S., Naesens, L. M. J., Clercq, E. D., Sureda, F. X., López-Querol, M., Camins, A., Pallàs, M., Prathalingam, S. R., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.10.028 · Cited by 38
Onajole, O. K., Govender, K., Govender, P., van Helden, P. D., Kruger, H. G., Maguire, G. E. M., Muthusamy, K., Pillay, K., Wiid, I. J. F., & Govender, T. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.07.015 · Cited by 38
Igarashi, M., Yoshimoto, N., Yamamoto, K., Shimizu, M., Ishizawa, M., Makishima, M., DeLuca, H. F., & Yamada, S. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.11.026 · Cited by 36
Menchise, V., Simone, G. D., Fiore, A. D., Scozzafava, A., & Supuran, C. T. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.022 · Cited by 36
Boovanahalli, S. K., Jin, X., Jin, Y., Kim, J. H., Đạt, N. T., Hong, Y., Lee, J. H., Jung, S., Lee, K., & Lee, J. J. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.09.005 · Cited by 31
Kaur, G., Narayanan, V. L., Risbood, P. A., Hollingshead, M. G., Stinson, S. F., Varma, R. K., & Sausville, E. A. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.12.003 · Cited by 29
Malo, M., Brive, L., Luthman, K., & Svensson, P. (2010) · ChemMedChem · doi:10.1002/cmdc.200900398 · Cited by 28
Pierard, G., Piérard-Franchimont, C., Paquet, P., & Quatresooz, P. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903386269 · Cited by 25
Pharmacokinetics and metabolism of rimantadine hydrochloride in mice and dogs
Hoffman, H. E., Gaylord, J. C., Blasecki, J. W., Shalaby, L. M., & Whitney, C. C. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.11.1699 · Cited by 22
Wrenchnolol Derivative Optimized for Gene Activation in Cells
Jung, D., Shimogawa, H., Kwon, Y., Mao, Q., Sato, S., Kamisuki, S., Kigoshi, H., & Uesugi, M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja900669k · Cited by 20
Jung, M. E., Wilson, A. M., & Simpkins, J. W. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.103630 · Cited by 20
Amantadine Therapy for Chronic Hepatitis C: A Dose Escalation Study
Smith, J. L., Riley, T., Bingaman, S. I., & Mauger, D. T. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30798.x · Cited by 19
Ferreira, A. M., Krishnamurthy, M., Moore, B. M., II, Finkelstein, D., & Bashford, D. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.11.059 · Cited by 16
Crystal Structures of Dipeptides Containing the Dmt-Tic Pharmacophore
Bryant, S. D., George, C. F., Flippen-Anderson, J. L., Deschamps, J. R., Salvadori, S., Balboni, G., Guerrini, R., & Lazarus, L. H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020330p · Cited by 13
The medium is the message: Glycosphingolipids and their soluble analogues
Rosa, M. D., Park, H.-J., Mylvaganum, M., Binnington, B., Lund, N., Branch, D. R., & Lingwood, C. A. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.10.016 · Cited by 12
Is adamantane a suitable substituent to pre-organize the acid orientation in E-selectin antagonists?
Titz, A., Patton, J., Alker, A., Porro, M., Schwardt, O., Hennig, M., Francotte, E. R., Magnani, J. L., & Ernst, B. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.07.025 · Cited by 4
Cited by
The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives
Wanka, L., Iqbal, K., & Schreiner, P. R. (2013) · Chemical Reviews · doi:10.1021/cr100264t · Cited by 696
Lipids and Lipid Derivatives for RNA Delivery
Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 626
Rational Design in Photopharmacology with Molecular Photoswitches
Kobauri, P., Dekker, F. J., Szymanski, W., & Feringa, B. L. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202300681 · Cited by 255
Privileged Electrophile Sensors: A Resource for Covalent Drug Development
Long, M. J. C., & Aye, Y. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.05.023 · Cited by 81
Adamantyl Analogues of Paracetamol as Potent Analgesic Drugs via Inhibition of TRPA1
Fresno, N., Pérez-Fernández, R., Goicoechea, C., Alkorta, I., Fernández-Carvajal, A., de la Torre-Martínez, R., Quirce, S., Ferrer-Montiel, A., Martín, M. I., Goya, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113841 · Cited by 22
Metadata
- Authors
- Liu, J., Obando, D., Liao, V., Lifa, T., & Codd, R.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 46
- Issue
- 6
- Pages
- 1949-1963
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2004627454
- Cited by
- 309
- References
- 121
- FWCI
- 17.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.